Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line
- 31 August 1996
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 32 (9), 1591-1597
- https://doi.org/10.1016/0959-8049(96)00113-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Anthracycline Antibiotics in Cancer TherapyDrugs, 1994
- Reversal of P-glycoprotein-associated multidrug resistance: The challenge continuesEuropean Journal Of Cancer, 1993
- Clinical trials of agents that reverse multidrug resistance. A literature reviewCancer, 1993
- Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cellsBritish Journal of Cancer, 1993
- The role of reduced growth rate in the development of drug resistance of HOB1 lymphoma cells to vincristineCancer Letters, 1993
- Cell cycle dependent uptake and release of anthracycline by drug-resistant and drug-sensitive human leukaemic K562 cellsBiochemical Pharmacology, 1993
- Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistanceEuropean Journal Of Cancer, 1992
- Drug resistance in oncology: from concepts to applicationsZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Potentiation of etoposide cytotoxicity against a human ovarian cancer cell line by pretreatment with non-toxic concentrations of methotrexate or aphidicolinEuropean Journal Of Cancer, 1992
- Pleiotropic-resistant phenotype is a multifactorial phenomenon in human colon carcinoma cell linesBritish Journal of Cancer, 1991